Livestock Animal Vaccination
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Hepatitis A and B Vaccine Market Research Report 2024
1 Hepatitis A and B Vaccine Market Overview
1.1 Product Overview and Scope of Hepatitis A and B Vaccine
1.2 Hepatitis A and B Vaccine Segment by Type
1.2.1 Global Hepatitis A and B Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Hepatitis A Vaccination
1.2.3 Hepatitis B Vaccination
1.3 Hepatitis A and B Vaccine Segment by Application
1.3.1 Global Hepatitis A and B Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Hepatitis A and B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Hepatitis A and B Vaccine Revenue 2017-2028
1.4.2 Global Hepatitis A and B Vaccine Sales 2017-2028
1.4.3 Hepatitis A and B Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Hepatitis A and B Vaccine Market Competition by Manufacturers
2.1 Global Hepatitis A and B Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Hepatitis A and B Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Hepatitis A and B Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Hepatitis A and B Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Hepatitis A and B Vaccine Market Competitive Situation and Trends
2.5.1 Hepatitis A and B Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hepatitis A and B Vaccine Players Market Share by Revenue
2.5.3 Global Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis A and B Vaccine Retrospective Market Scenario by Region
3.1 Global Hepatitis A and B Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Hepatitis A and B Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Hepatitis A and B Vaccine Market Facts & Figures by Country
3.3.1 North America Hepatitis A and B Vaccine Sales by Country
3.3.2 North America Hepatitis A and B Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Hepatitis A and B Vaccine Market Facts & Figures by Country
3.4.1 Europe Hepatitis A and B Vaccine Sales by Country
3.4.2 Europe Hepatitis A and B Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hepatitis A and B Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Hepatitis A and B Vaccine Sales by Region
3.5.2 Asia Pacific Hepatitis A and B Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Hepatitis A and B Vaccine Market Facts & Figures by Country
3.6.1 Latin America Hepatitis A and B Vaccine Sales by Country
3.6.2 Latin America Hepatitis A and B Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hepatitis A and B Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Hepatitis A and B Vaccine Sales by Country
3.7.2 Middle East and Africa Hepatitis A and B Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hepatitis A and B Vaccine Historic Market Analysis by Type
4.1 Global Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Hepatitis A and B Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Hepatitis A and B Vaccine Price by Type (2017-2022)
5 Global Hepatitis A and B Vaccine Historic Market Analysis by Application
5.1 Global Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Hepatitis A and B Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Hepatitis A and B Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GSK Hepatitis A and B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merck Hepatitis A and B Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi Hepatitis A and B Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sinovac
6.4.1 Sinovac Corporation Information
6.4.2 Sinovac Description and Business Overview
6.4.3 Sinovac Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sinovac Hepatitis A and B Vaccine Product Portfolio
6.4.5 Sinovac Recent Developments/Updates
6.5 Zhejiang Pukang
6.5.1 Zhejiang Pukang Corporation Information
6.5.2 Zhejiang Pukang Description and Business Overview
6.5.3 Zhejiang Pukang Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zhejiang Pukang Hepatitis A and B Vaccine Product Portfolio
6.5.5 Zhejiang Pukang Recent Developments/Updates
6.6 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Changchun Institute of Biological Hepatitis A and B Vaccine Product Portfolio
6.6.5 Changchun Institute of Biological Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 KM Biologics Hepatitis A and B Vaccine Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 IMBCAMS
6.8.1 IMBCAMS Corporation Information
6.8.2 IMBCAMS Description and Business Overview
6.8.3 IMBCAMS Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 IMBCAMS Hepatitis A and B Vaccine Product Portfolio
6.8.5 IMBCAMS Recent Developments/Updates
6.9 Convac
6.9.1 Convac Corporation Information
6.9.2 Convac Description and Business Overview
6.9.3 Convac Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Convac Hepatitis A and B Vaccine Product Portfolio
6.9.5 Convac Recent Developments/Updates
6.10 NCPC
6.10.1 NCPC Corporation Information
6.10.2 NCPC Description and Business Overview
6.10.3 NCPC Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 NCPC Hepatitis A and B Vaccine Product Portfolio
6.10.5 NCPC Recent Developments/Updates
6.11 Bio Kangtai
6.11.1 Bio Kangtai Corporation Information
6.11.2 Bio Kangtai Hepatitis A and B Vaccine Description and Business Overview
6.11.3 Bio Kangtai Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Bio Kangtai Hepatitis A and B Vaccine Product Portfolio
6.11.5 Bio Kangtai Recent Developments/Updates
6.12 Dynavax
6.12.1 Dynavax Corporation Information
6.12.2 Dynavax Hepatitis A and B Vaccine Description and Business Overview
6.12.3 Dynavax Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Dynavax Hepatitis A and B Vaccine Product Portfolio
6.12.5 Dynavax Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Hepatitis A and B Vaccine Description and Business Overview
6.13.3 Hissen Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Hissen Hepatitis A and B Vaccine Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 LG Life Sciences
6.14.1 LG Life Sciences Corporation Information
6.14.2 LG Life Sciences Hepatitis A and B Vaccine Description and Business Overview
6.14.3 LG Life Sciences Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 LG Life Sciences Hepatitis A and B Vaccine Product Portfolio
6.14.5 LG Life Sciences Recent Developments/Updates
6.15 Serum Institute
6.15.1 Serum Institute Corporation Information
6.15.2 Serum Institute Hepatitis A and B Vaccine Description and Business Overview
6.15.3 Serum Institute Hepatitis A and B Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Serum Institute Hepatitis A and B Vaccine Product Portfolio
6.15.5 Serum Institute Recent Developments/Updates
7 Hepatitis A and B Vaccine Manufacturing Cost Analysis
7.1 Hepatitis A and B Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hepatitis A and B Vaccine
7.4 Hepatitis A and B Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hepatitis A and B Vaccine Distributors List
8.3 Hepatitis A and B Vaccine Customers
9 Hepatitis A and B Vaccine Market Dynamics
9.1 Hepatitis A and B Vaccine Industry Trends
9.2 Hepatitis A and B Vaccine Market Drivers
9.3 Hepatitis A and B Vaccine Market Challenges
9.4 Hepatitis A and B Vaccine Market Restraints
10 Global Market Forecast
10.1 Hepatitis A and B Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hepatitis A and B Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Hepatitis A and B Vaccine by Type (2023-2028)
10.2 Hepatitis A and B Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hepatitis A and B Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Hepatitis A and B Vaccine by Application (2023-2028)
10.3 Hepatitis A and B Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hepatitis A and B Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Hepatitis A and B Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hepatitis A and B Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Hepatitis A and B Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Hepatitis A and B Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Hepatitis A and B Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Hepatitis A and B Vaccine Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Hepatitis A and B Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Hepatitis A and B Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Hepatitis A and B Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Hepatitis A and B Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Hepatitis A and B Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hepatitis A and B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A and B Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hepatitis A and B Vaccine Sales by Region (2017-2022) & (Units)
Table 16. Global Hepatitis A and B Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Hepatitis A and B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 20. North America Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 24. Europe Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Hepatitis A and B Vaccine Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Hepatitis A and B Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Hepatitis A and B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 32. Latin America Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Hepatitis A and B Vaccine Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Hepatitis A and B Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Hepatitis A and B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Hepatitis A and B Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Hepatitis A and B Vaccine Sales by Type (2017-2022) & (Units)
Table 40. Global Hepatitis A and B Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Hepatitis A and B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Hepatitis A and B Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Hepatitis A and B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Hepatitis A and B Vaccine Sales (Units) by Application (2017-2022)
Table 45. Global Hepatitis A and B Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Hepatitis A and B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Hepatitis A and B Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Hepatitis A and B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. GSK Corporation Information
Table 50. GSK Description and Business Overview
Table 51. GSK Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GSK Hepatitis A and B Vaccine Product
Table 53. GSK Recent Developments/Updates
Table 54. Merck Corporation Information
Table 55. Merck Description and Business Overview
Table 56. Merck Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Merck Hepatitis A and B Vaccine Product
Table 58. Merck Recent Developments/Updates
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Sanofi Hepatitis A and B Vaccine Product
Table 63. Sanofi Recent Developments/Updates
Table 64. Sinovac Corporation Information
Table 65. Sinovac Description and Business Overview
Table 66. Sinovac Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sinovac Hepatitis A and B Vaccine Product
Table 68. Sinovac Recent Developments/Updates
Table 69. Zhejiang Pukang Corporation Information
Table 70. Zhejiang Pukang Description and Business Overview
Table 71. Zhejiang Pukang Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Zhejiang Pukang Hepatitis A and B Vaccine Product
Table 73. Zhejiang Pukang Recent Developments/Updates
Table 74. Changchun Institute of Biological Corporation Information
Table 75. Changchun Institute of Biological Description and Business Overview
Table 76. Changchun Institute of Biological Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Changchun Institute of Biological Hepatitis A and B Vaccine Product
Table 78. Changchun Institute of Biological Recent Developments/Updates
Table 79. KM Biologics Corporation Information
Table 80. KM Biologics Description and Business Overview
Table 81. KM Biologics Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. KM Biologics Hepatitis A and B Vaccine Product
Table 83. KM Biologics Recent Developments/Updates
Table 84. IMBCAMS Corporation Information
Table 85. IMBCAMS Description and Business Overview
Table 86. IMBCAMS Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. IMBCAMS Hepatitis A and B Vaccine Product
Table 88. IMBCAMS Recent Developments/Updates
Table 89. Convac Corporation Information
Table 90. Convac Description and Business Overview
Table 91. Convac Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Convac Hepatitis A and B Vaccine Product
Table 93. Convac Recent Developments/Updates
Table 94. NCPC Corporation Information
Table 95. NCPC Description and Business Overview
Table 96. NCPC Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. NCPC Hepatitis A and B Vaccine Product
Table 98. NCPC Recent Developments/Updates
Table 99. Bio Kangtai Corporation Information
Table 100. Bio Kangtai Description and Business Overview
Table 101. Bio Kangtai Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Bio Kangtai Hepatitis A and B Vaccine Product
Table 103. Bio Kangtai Recent Developments/Updates
Table 104. Dynavax Corporation Information
Table 105. Dynavax Description and Business Overview
Table 106. Dynavax Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Dynavax Hepatitis A and B Vaccine Product
Table 108. Dynavax Recent Developments/Updates
Table 109. Hissen Corporation Information
Table 110. Hissen Description and Business Overview
Table 111. Hissen Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Hissen Hepatitis A and B Vaccine Product
Table 113. Hissen Recent Developments/Updates
Table 114. LG Life Sciences Corporation Information
Table 115. LG Life Sciences Description and Business Overview
Table 116. LG Life Sciences Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. LG Life Sciences Hepatitis A and B Vaccine Product
Table 118. LG Life Sciences Recent Developments/Updates
Table 119. Serum Institute Corporation Information
Table 120. Serum Institute Description and Business Overview
Table 121. Serum Institute Hepatitis A and B Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Serum Institute Hepatitis A and B Vaccine Product
Table 123. Serum Institute Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Hepatitis A and B Vaccine Distributors List
Table 127. Hepatitis A and B Vaccine Customers List
Table 128. Hepatitis A and B Vaccine Market Trends
Table 129. Hepatitis A and B Vaccine Market Drivers
Table 130. Hepatitis A and B Vaccine Market Challenges
Table 131. Hepatitis A and B Vaccine Market Restraints
Table 132. Global Hepatitis A and B Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 133. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Hepatitis A and B Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Hepatitis A and B Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Hepatitis A and B Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 137. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Hepatitis A and B Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Hepatitis A and B Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Hepatitis A and B Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 141. Global Hepatitis A and B Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Hepatitis A and B Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Hepatitis A and B Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis A and B Vaccine
Figure 2. Global Hepatitis A and B Vaccine Market Share by Type in 2021 & 2028
Figure 3. Hepatitis A Vaccination Product Picture
Figure 4. Hepatitis B Vaccination Product Picture
Figure 5. Global Hepatitis A and B Vaccine Market Share by Application in 2021 & 2028
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global Hepatitis A and B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Hepatitis A and B Vaccine Market Size (2017-2028) & (US$ Million)
Figure 11. Global Hepatitis A and B Vaccine Sales (2017-2028) & (Units)
Figure 12. Hepatitis A and B Vaccine Sales Share by Manufacturers in 2021
Figure 13. Global Hepatitis A and B Vaccine Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Hepatitis A and B Vaccine Players: Market Share by Revenue in 2021
Figure 15. Hepatitis A and B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Hepatitis A and B Vaccine Sales Market Share by Region (2017-2022)
Figure 17. Global Hepatitis A and B Vaccine Sales Market Share by Region in 2021
Figure 18. Global Hepatitis A and B Vaccine Revenue Market Share by Region (2017-2022)
Figure 19. Global Hepatitis A and B Vaccine Revenue Market Share by Region in 2021
Figure 20. United States Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Hepatitis A and B Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Hepatitis A and B Vaccine by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Hepatitis A and B Vaccine
Figure 44. Manufacturing Process Analysis of Hepatitis A and B Vaccine
Figure 45. Hepatitis A and B Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK Merck Sanofi Sinovac Zhejiang Pukang Changchun Institute of Biological KM Biologics IMBCAMS Convac NCPC Bio Kangtai Dynavax Hissen LG Life Sciences Serum Institute